首页> 外文会议>Bioinformatics and Biomedical Engineering , 2009. ICBBE 2009 >Transcriptional Profile of CYP3As and Functional Expression of CYP3A29 from Piglets
【24h】

Transcriptional Profile of CYP3As and Functional Expression of CYP3A29 from Piglets

机译:仔猪CYP3A的转录特征及CYP3A29的功能表达

获取原文

摘要

Expression profile of CYP3A individuals from piglets and characterization of CYP3A29 were investigated. Real-Time PCR showed that the liver and small intestines present the highest expression levels of CYP3A29, a human CYP3A4 homolog. The CYP3A29 was functional expressed in Bac-to-Bac baculovirus expression system together with NADPH p450 reductase (NPR) and cytochrome b5. For nifedipine oxidation (NOD) activity, recombinant CYP3A29 system showed similar enzyme kinetic parameters (Km = 14.1 ~ 25.3 muM) to human recombinant CYP3A4, and a little variant to liver microsomes (Km = 29.6 ~ 45.2 muM) from piglets. The NOD activity of recombinant CYP3A29 was strongly inhibited by ketoconazole (KET) and troleandomycin (TAO), and was slightly changed by inhibitors for other p450 enzymes from human. These results provided in detailed information of the characterizations of CYP3A29. We conclude from these results that caution should be hold when specific inhibitors or probes for human p450 enzymes are employed to investigate the veterinary drug metabolism.
机译:研究了仔猪CYP3A个体的表达谱和CYP3A29的特征。实时PCR显示,肝脏和小肠的CYP3A29(人类CYP3A4同源物)的表达水平最高。 CYP3A29与NADPH p450还原酶(NPR)和细胞色素b5一起在Bac-to-Bac杆状病毒表达系统中表达。对于硝苯地平氧化(NOD)活性,重组CYP3A29系统显示出与人重组CYP3A4相似的酶动力学参数(Km = 14.1〜25.3μM),并且与仔猪的肝微粒体(Km = 29.6〜45.2μM)略有不同。重组CYP3A29的NOD活性被酮康唑(KET)和曲安霉素(TAO)强烈抑制,并被人类其他p450酶的抑制剂轻微改变。这些结果提供了CYP3A29表征的详细信息。从这些结果中我们得出结论,当采用人类p450酶的特异性抑制剂或探针研究兽药代谢时,应谨慎行事。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号